Dec 11,2015

Senseonics Holdings, Inc. and ASN Technologies, Inc. Announce Closing of Merger

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring system for people with diabetes, announced today the completion of its merger with ASN Technologies, Inc. (OTCBB: AWSN). “The completion of the merger marks a significant milestone for Senseonics as we debut as a public company, backed by a group of highly regarded investors who support our pursuit to commercialize our continuous glucose monitoring system for people with diabetes,” said Tim Goodnow, PhD, Chief Executive Officer of Senseonics.

COLLABORATION MERGERS & ACQUISITION

#product & service

View Analyst & Ambassador Comments
Go to original news
Dec 16,2015

Dario Diabetes Management Solution Garners Global Media Coverage

LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced its personalized smart blood glucose meter has recently been featured in numerous health and technology publications in the U.S. and UK.

View Analyst & Ambassador Comments
Go to original news
Dec 22,2015

LabStyle Innovations Receives U.S. FDA Marketing Clearance for the Dario Blood Glucose Monitoring System

LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that the United States Food and Drug Administration (FDA) has granted 510(k) clearance for the Dario Blood Glucose Monitoring System, including its components, the Dario Blood Glucose Meter, Dario Blood Glucose Test Strips, Dario Glucose Control Solutions and the Dario app on the Apple iOS 6.1 platform and higher.

REGULATORY FDA

#bgm

View Analyst & Ambassador Comments
Go to original news
Jan 07,2014

H2 Launches Health2Sync, A Tech-Savvy Way To Help Diabetics Manage And Track Their Glucose

Today at the TechCrunch Hardware Battlefield at CES, H2 debuted its Health2Sync technology, a combination of hardware and software aimed at helping diabetics better manage their glucose levels by providing them with a digital solution to a manual problem. Health2Sync introduces a smart cable and app for diabetes patients that enables simple data transfer, tracking, and interpretation from existing glucometers to their smartphones, including features that let partners provide monitoring and encouragement remotely to their loved ones.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 10,2014

Will Samsung tap Glooko for S Health?

Glooko has raised $7 million from Samsung Ventures and Lifeforce Ventures, as well as existing investors including The Social + Capital Partnership, Sundeep Madra and Yogen Dalal. The investment move from Samsung is particularly interesting given two other recent pieces of news: Glooko's recent expansion into Android compatibility, and Samsung's December FDA clearance for S Health, which likely allowed the mobile company to connect its app to additional medical devices.

View Analyst & Ambassador Comments
Go to original news
Jan 21,2014

Glooko, Joslin partner to develop diabetes management platform

Glooko, maker of diabetes management software and glucometer connector cables, is teaming up with the Joslin Diabetes Center to co-develop a "virtual Joslin" remote diabetes management platform to be offered to patients via private or government payors. Glooko and Joslin will work together on the platform, with Joslin providing educational content as well as ways to analyze and work with the data generated by patients' connected devices.

COLLABORATION PARTNERSHIP

#product & service

#rpm

View Analyst & Ambassador Comments
Go to original news
Jan 21,2014

Report: 24M people will use diabetes apps in 2018

Only about 1.2 percent of people with diabetes who own a smartphone use a mobile application to manage their condition, according to a new report by Research2Guidance. That's a group of about 1.6 million users. However, the firm predicts that by 2018 that number will rise to 24 million users, or 7.8 percent of smartphone owners with diabetes.

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 24,2014

So many diabetes apps but so few users

The latest report on adoption of mHealth apps paints an all-too-familiar picture: Consumers aren't using the apps because they're too difficult to use. But there is hope for the future. The report comes from the German market firm Research2Guidance and takes a look at the growing market for mobile diabetes apps.

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 24,2014

Mississippi telehealth project may be a model for the nation

A remote care management pilot that makes use of mHealth tools and services has been launched in Mississippi. Officials hope it will make an impact in the state with the highest percentage of adult diabetics and cut into the $3 billion in diabetes-related health costs that the state incurs each year. The Diabetes Telehealth Network was unveiled this week by Gov. Phil Bryant. The public-private partnership, which includes the University of Mississippi Medical Center, North Sunflower Medical Center, GE Healthcare, Intel-GE Care Innovations and CSpire Wireless, is being billed as the first of its kind, targeting at-risk residents in underserves areas.

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Jan 03,2014

Insulet Corporation to Present at 32nd Annual J.P. Morgan Healthcare Conference

Insulet Corporation, the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the 32nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. Management is scheduled to present an overview of the Company on Wednesday, January 15, 2014 at 2:00 p.m. PT (5:00 p.m. ET).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES